NVS earnings call for the period ending June 30, 2024.
Investors were caught off guard by a decision on the research and development front.
These reliable healthcare companies look attractive no matter how you slice it.
Monday U.S. Featured Earnings Goldman Sachs Group Inc. (NYSE:GS) (Q2) EPS of $8.70, compared ...
/CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) today announced the launch of a new health equity initiative, aimed at addressing health disparities...
/CNW/ - Novartis Canada is pleased to announce the winners of the 2024 Novartis Oncology Young Canadian Investigator Awards (NOYCIA), an annual national...
Psoriatic arthritis is a chronic, autoimmune disease form of arthritis that causes joint inflammation (swelling, pain, stiffness) and occurs with skin...
/CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that Health Canada has granted Cosentyx® (secukinumab) with a Notice of...
These three companies have track records that should please investors.
The dividend is just one reason to buy these stocks.